The price take-down is a last desperate attempt be
Post# of 72433
![Avatar](/images/ProfileImages/424989898_3046_Avatar jpeg2.jpg)
Unlike most other small biotechs, we have multiple completely different drugs in development. Any one of them having good results in their current phase would justify a price of 10-20/share.
Why else do you think such a huge effort is being made to try to scare people out of this stock?
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)